145 related articles for article (PubMed ID: 20123470)
1. Beyond executive function: non-executive cognitive abilities in individuals with PKU.
Janzen D; Nguyen M
Mol Genet Metab; 2010; 99 Suppl 1():S47-51. PubMed ID: 20123470
[TBL] [Abstract][Full Text] [Related]
2. Are neuropsychological impairments in children with early-treated phenylketonuria (PKU) related to white matter abnormalities or elevated phenylalanine levels?
Anderson PJ; Wood SJ; Francis DE; Coleman L; Anderson V; Boneh A
Dev Neuropsychol; 2007; 32(2):645-68. PubMed ID: 17931123
[TBL] [Abstract][Full Text] [Related]
3. Disruption of prefrontal function and connectivity in individuals with phenylketonuria.
Christ SE; Moffitt AJ; Peck D
Mol Genet Metab; 2010; 99 Suppl 1():S33-40. PubMed ID: 20123468
[TBL] [Abstract][Full Text] [Related]
4. Evidence for the importance of dopamine for prefrontal cortex functions early in life.
Diamond A
Philos Trans R Soc Lond B Biol Sci; 1996 Oct; 351(1346):1483-93; discussion 1494. PubMed ID: 8941960
[TBL] [Abstract][Full Text] [Related]
5. Executive function in phenylketonuria (PKU): Insights from the Behavior Rating Inventory of Executive Function (BRIEF) and a large sample of individuals with PKU.
Christ SE; Clocksin HE; Burton BK; Grant ML; Waisbren S; Paulin MC; Bilder DA; White DA; Saville C
Neuropsychology; 2020 May; 34(4):456-466. PubMed ID: 32202818
[TBL] [Abstract][Full Text] [Related]
6. A comprehensive assessment of neurocognitive and psychological functioning in adults with early-treated phenylketonuria.
Clocksin HE; Abbene EE; Christ S
J Int Neuropsychol Soc; 2023 Aug; 29(7):641-650. PubMed ID: 36134437
[TBL] [Abstract][Full Text] [Related]
7. Prefrontal cortex cognitive deficits in children treated early and continuously for PKU.
Diamond A; Prevor MB; Callender G; Druin DP
Monogr Soc Res Child Dev; 1997; 62(4):i-v, 1-208. PubMed ID: 9421921
[TBL] [Abstract][Full Text] [Related]
8. A volumetric study of basal ganglia structures in individuals with early-treated phenylketonuria.
Bodner KE; Aldridge K; Moffitt AJ; Peck D; White DA; Christ SE
Mol Genet Metab; 2012 Nov; 107(3):302-7. PubMed ID: 23006929
[TBL] [Abstract][Full Text] [Related]
9. Executive function in early-treated phenylketonuria: profile and underlying mechanisms.
Christ SE; Huijbregts SC; de Sonneville LM; White DA
Mol Genet Metab; 2010; 99 Suppl 1():S22-32. PubMed ID: 20123466
[TBL] [Abstract][Full Text] [Related]
10. Neuropsychological functioning in children with early-treated phenylketonuria: impact of white matter abnormalities.
Anderson PJ; Wood SJ; Francis DE; Coleman L; Warwick L; Casanelia S; Anderson VA; Boneh A
Dev Med Child Neurol; 2004 Apr; 46(4):230-8. PubMed ID: 15077700
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychology of early-treated phenylketonuria: specific executive function deficits.
Welsh MC; Pennington BF; Ozonoff S; Rouse B; McCabe ER
Child Dev; 1990 Dec; 61(6):1697-713. PubMed ID: 2083493
[TBL] [Abstract][Full Text] [Related]
12. Executive functioning in context: Relevance for treatment and monitoring of phenylketonuria.
Huijbregts SC; Gassió R; Campistol J
Mol Genet Metab; 2013; 110 Suppl():S25-30. PubMed ID: 24206933
[TBL] [Abstract][Full Text] [Related]
13. Biochemical markers associated with executive function in adolescents with early and continuously treated phenylketonuria.
Sharman R; Sullivan K; Young R; McGill J
Clin Genet; 2009 Feb; 75(2):169-74. PubMed ID: 19215250
[TBL] [Abstract][Full Text] [Related]
14. White matter integrity and executive abilities in individuals with phenylketonuria.
Antenor-Dorsey JA; Hershey T; Rutlin J; Shimony JS; McKinstry RC; Grange DK; Christ SE; White DA
Mol Genet Metab; 2013 Jun; 109(2):125-31. PubMed ID: 23608077
[TBL] [Abstract][Full Text] [Related]
15. Neuropsychological assessment of adults with phenylketonuria using the NIH toolbox.
Christ SE; Clocksin HE; Zalik M; Goodlett BD; Sacharow SJ; Abbene EE
Mol Genet Metab; 2023 May; 139(1):107579. PubMed ID: 37099821
[TBL] [Abstract][Full Text] [Related]
16. A preliminary report on dopamine system reactivity in PKU: acute effects of haloperidol on neuropsychological, physiological, and neuroendocrine functions.
Luciana M; Hanson KL; Whitley CB
Psychopharmacology (Berl); 2004 Aug; 175(1):18-25. PubMed ID: 15024549
[TBL] [Abstract][Full Text] [Related]
17. Executive functioning, memory, and learning in phenylketonuria.
Channon S; German E; Cassina C; Lee P
Neuropsychology; 2004 Oct; 18(4):613-20. PubMed ID: 15506828
[TBL] [Abstract][Full Text] [Related]
18. Executive functioning in children and adolescents with phenylketonuria.
VanZutphen K; Packman W; Sporri L; Needham M; Morgan C; Weisiger K; Packman S
Clin Genet; 2007 Jul; 72(1):13-8. PubMed ID: 17594394
[TBL] [Abstract][Full Text] [Related]
19. A comparison of phenylketonuria with attention deficit hyperactivity disorder: do markedly different aetiologies deliver common phenotypes?
Stevenson M; McNaughton N
Brain Res Bull; 2013 Oct; 99():63-83. PubMed ID: 24140048
[TBL] [Abstract][Full Text] [Related]
20. A systematic review of cognitive functioning in early treated adults with phenylketonuria.
Hofman DL; Champ CL; Lawton CL; Henderson M; Dye L
Orphanet J Rare Dis; 2018 Aug; 13(1):150. PubMed ID: 30165883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
